Bone biopsy and densitometry findings in a child with Camurati-Engelmann disease.

Abstract

Progressive diaphyseal dysplasia (MIM 131300), also known as Camurati-Engelmann disease (CED), is a rare autosomal dominant craniotubular dysplasia caused by mutations in the transforming growth factor beta1 (TGF-beta1) gene. Radiographs of the long bones of a 9-year-old boy presenting with waddling gait, muscular weakness, underweight, and severe skeletal pain showed symmetric diaphyseal cortical thickening pathognomonic for CED. The diagnosis was verified by detecting a mutation in exon 4 of the TGF-beta1 gene. Full body bone mineral densitometry studies performed before treatment with prednisolone were indicative for osteoporosis (Z-scores for the lumbar spine and femoral neck -2.3 and -3.2, respectively). A transiliac bone biopsy showed markedly reduced trabecular bone volume. Oral prednisolone was initiated, and subsequently, pamidronate infusions were commenced in an attempt to prevent progression of osteoporosis. To our knowledge, this is the first time bone biopsy and bone mineral densitometry studies have been performed and bisphosphonate treatment evaluated in a child with CED.

• Authors: Jonas Bondestam, Mervi K Mäyränpää, Shiro Ikegawa, Eino Marttinen, Heikki Kröger, Outi Mäkitie
• Journal: Clinical rheumatology (Clin Rheumatol) Vol. 26 Issue 10 Pg. 1773-7 (Oct 2007) ISSN: 0770-3198 [Print] Germany
• PMID: 17206397 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Diphosphonates
• Transforming Growth Factor beta1

Topics

• Biopsy
• Bone and Bones (pathology)
• Camurati-Engelmann Syndrome (diagnosis, pathology)
• Child
• Densitometry (methods)
• Diphosphonates (chemistry)
• Exons
• Humans
• Male
• Mutation
• Osteoporosis
• Transforming Growth Factor beta1 (metabolism)
• Treatment Outcome
• Whole Body Imaging